title: Specific neutralizing antiserum against a polypeptide growth inhibitor for mammary cells purified from bovine mammary gland.
abstract: A recently published method for purification of a new inhibitor of growth of mammary cells in vitro from bovine mammary gland has been modified to yield several hundred micrograms of inhibitor per kg of glandular tissue. The inhibitory effect exerted by this preparation to Ehrlich ascites mammary carcinoma cells fulfilled all biological criteria of specificity established earlier for preparations obtained by other means, the most important being that the inhibitory effect is abolished by the epidermal growth factor and insulin. The preparation is shown to consist mainly of a protein of 13 kDa which appears to be not glycosylated. An antiserum raised in mice against the inhibitor is demonstrated to be specific for the 13 kDa bovine mammary gland protein. Neutralization of the inhibitory activity by the specific antiserum strongly supports the view that the 13 kDa protein is indeed the carrier of inhibitory activity. First data on tissue distribution obtained with an enzyme-linked immunosorbent assay revealed a high concentration of the anti-inhibitor-antiserum-reactive antigen in bovine lactating but not in non-lactating mammary gland tissue and in milk fat globule membranes. Some reactivity was also found in bovine lung. These data are interpreted with respect to a possible physiological significance of the growth inhibitor.
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology*; D002352:Carrier Proteins; D002417:Cattle; D002455:Cell Division / Q000187:drug effects; D000074026:Fatty Acid Binding Protein 3; D050556:Fatty Acid-Binding Proteins; D005260:Female; D006131:Growth Inhibitors / Q000276:immunology* / Q000302:isolation & purification / Q000494:pharmacology; D007774:Lactation; D008321:Mammary Glands, Animal / Q000032:analysis* / Q000276:immunology / Q000502:physiology; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D009500:Neutralization Tests; D010455:Peptides / Q000276:immunology* / Q000302:isolation & purification / Q000494:pharmacology; D011247:Pregnancy; D014018:Tissue Distribution
chemical_list: D000906:Antibodies; D002352:Carrier Proteins; C493409:Fabp3 protein, mouse; D000074026:Fatty Acid Binding Protein 3; D050556:Fatty Acid-Binding Proteins; D006131:Growth Inhibitors; D010455:Peptides